Stock Analiz

Medline Inc. (MDLN) stock forecast and price target

Price $39.47 · data as of November 13, 2026

12-month price target

Average target$45.35
Upside / downside+14.9%
Analysts26
ConsensusBuy
Low $34.00Average $45.35High $55.00

Gold marker: average target · white marker: today’s price ($39.47)

Analyst ratings

Strong buy 6Buy 16Hold 5Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$1.57+19.0%$31.4B
Next fiscal year
ends December 31, 2027
$1.54−1.8%$33.9B
Next quarter
ends December 31, 2026
$0.40+28.0%$8.5B
Quarter after
ends March 31, 2027
$0.34+2.7%$7.9B

Consensus of the analysts covering Medline, updated daily. In the last 30 days 12 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 14.9% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Medline’s intrinsic value about 48% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Medline stock price target?

The average 12-month target from 26 analysts is $45.35, 14.9% above the current price of $39.47 Targets range from $34.00 to $55.00.

Is Medline a buy according to analysts?

The consensus rating is “Buy” (6 strong buy, 16 buy, 5 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Medline expected to earn?

Analysts expect EPS of $1.57 for the fiscal year ending December 31, 2026 and $1.54 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.